OKYO
OKYO Pharma Ltd ADR
NASDAQ: OKYO · HEALTHCARE · BIOTECHNOLOGY
$1.56
+2.63% today
Updated 2026-04-30
Market cap
$82.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
OKYO Pharma Ltd ADR (OKYO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | $77242.00 | — | — | — | — | — | — | $219.00 | $5971.00 | $13086.00 | $2423.00 | $3797.00 | $3866.00 | $2563.00 |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | $-219.00 | $-5971.00 | $-13086.00 | $-2423.00 | $-3797.00 | $-3866.00 | $-2563.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | — | — | $3.04M | $517457.00 | $348347.00 | $1.61M | $6.34M | $8.24M | $2.25M |
| SG&A | — | — | — | $832408.00 | — | $4.67M | $4.61M | $1.74M | $1.05M | $363199.00 | $573427.00 | — | — | $886909.00 | $4.92M | — | — | — |
| Operating income | $-3.17M | $15.10M | $28.61M | $-1.70M | $-5.11M | $-4.92M | $-4.77M | $-1.75M | $-1.12M | $-363269.00 | $-28.29M | $-4.54M | $-1.52M | $-4.13M | $-6.23M | $-13.09M | $-15.69M | $-7.19M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-2.90M | $15.10M | $33.93M | $-1.70M | $-5.09M | $-4.70M | $-4.67M | $2.52M | $-1.14M | $-363269.00 | $26.17M | $-4.54M | $-1.51M | $-3.35M | $-6.21M | $-13.18M | $-15.75M | $-7.08M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-3.17M | $15.10M | $28.61M | $-1.70M | $-5.11M | $-4.72M | $-13.39M | $-1.75M | $-1.12M | $-363269.00 | $-78.44M | $-4.54M | $-1.52M | $-3.37M | $-6.22M | $-13.19M | $-15.75M | $-7.09M |
| Interest expense | $174000.00 | $266000.00 | $1000.00 | $88000.00 | $13000.00 | $61352.00 | $4141.00 | $11678.00 | $8600.00 | $3545.00 | $0.00 | $0.00 | $1156.00 | $1123.00 | $0.00 | $96687.00 | $1.05M | $883647.00 |
| Income tax | $-270000.00 | $266000.00 | $5.26M | $-142000.00 | $-895000.00 | $0.00 | $4141.00 | $6.76M | $-189987.00 | $-100798.00 | $0.00 | $-172000.00 | $-76194.00 | $-24994.00 | $-787000.00 | $-12202.00 | $22415.00 | $-3.26M |
| Effective tax rate | 8.3% | 1.8% | 29.3% | 8.1% | 15.7% | 0.0% | -0.0% | -452.4% | 18.8% | 29.4% | 0.0% | 3.4% | 4.7% | 0.7% | 12.7% | 0.1% | -0.1% | 41.0% |
| Net income | $-2.97M | $14.33M | $12.67M | $-1.62M | $-4.80M | $-4.84M | $-13.95M | $-8.26M | $-820171.00 | $-241927.00 | $-28.30M | $-4.89M | $-1.54M | $-3.35M | $-5.43M | $-13.27M | $-16.83M | $-4.71M |
| Net income growth (YoY) | — | +581.9% | -11.6% | -112.8% | -197.2% | -0.7% | -188.2% | +40.8% | +90.1% | +70.5% | -11597.3% | +82.7% | +68.5% | -117.5% | -61.9% | -144.4% | -26.8% | +72.0% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |